When looking at the individual pre-treatments, the improvements in the TSQM domains failed to reach statistical significance, possibly due to the small number of patients in the various groups (data not shown).
← all excerpts
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.
1
—
—